![Gemin X Pharmaceuticals](https://storage.googleapis.com/dealroom-static-production/null/company-100.png)
Gemin X Pharmaceuticals
VerifiedDevelops and commercializes targeted cancer therapeutics to improve the lives of patients.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$32—48m (Dealroom.co estimates Aug 2010.)
Malvern Iowa (HQ & founding location)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $0.0 | round | |
investor investor investor investor investor investor investor investor investor investor | $0.0 | round | |
N/A | $0.0 | round | |
investor investor | $0.0 | round | |
investor investor | $0.0 | round | |
$225m | Acquisition | ||
Total Funding | 000k |
Related Content
Recent News about Gemin X Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.